Krystal Biotech's VYJUVEK sees strong growth with $1B+ 2025 sales forecast. Check out why I rate KRYS as a Strong Buy and my ...

Q4 2024 Earnings Call Transcript February 20, 2025 Choice Hotels International, Inc. beats earnings expectations. Reported ...

Q4 2024 Earnings Call Transcript February 20, 2025 Universal Display Corporation misses on earnings expectations. Reported ...

Fidelity National Financial, Inc. ( NYSE: FNF) Q4 2024 Earnings Call Transcript February 21, 2025 11:00 AM ET Lisa Parker - Senior Vice President, Investor and External Relations Mike Nolan - Chief ...

Highlights:GAAP net income of $0.32 and distributable earnings of $0.40, per diluted common share1Declares cash dividend on common ...

The real estate investment trust reported fourth quarter revenue Friday of $976.1 million in revenue, up 4.7 percent from a ...

Integer Holdings Corporation (NYSE: ITGR), a prominent manufacturer of medical devices, announced its financial performance for the fourth quarter and the full year that ended on December 31, 2024, on ...

After testing the program last year, the grocer will begin a phased rollout in Q3, CEO Jack Sinclair told investors.

Ted Harris, Chairman, President, and CEO of Balchem said, "The fourth quarter capped off another very strong year for Balchem ...